Cargando…
Stage-associated differences in the serum N- and O-glycan profiles of patients with non-small cell lung cancer
BACKGROUND: Lung cancer is the leading cause of cancer death in China and around the world. Early detection is key to improving the survival rate of non-small cell lung cancer (NSCLC). Alteration in glycosylation has been observed in cancers, and glycans can be a source for the development of new bi...
Autores principales: | Liang, Yiqian, Han, Peng, Wang, Ting, Ren, Hui, Gao, Lei, Shi, Puyu, Zhang, Shuo, Yang, Aimin, Li, Zheng, Chen, Mingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509814/ https://www.ncbi.nlm.nih.gov/pubmed/31168300 http://dx.doi.org/10.1186/s12014-019-9240-6 |
Ejemplares similares
-
EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non-small cell lung cancer cells
por: Gao, Lei, et al.
Publicado: (2021) -
Fucosyltransferase 8 is Overexpressed and Influences Clinical Outcomes in Lung Adenocarcinoma Patients
por: Liang, Yiqian, et al.
Publicado: (2022) -
Increased expression of core-fucosylated glycans in human lung squamous cell carcinoma
por: Ma, Tianran, et al.
Publicado: (2019) -
Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis
por: Hatakeyama, Shingo, et al.
Publicado: (2013) -
N‐glycan profiling alterations of serum and immunoglobulin G in immune thrombocytopenia
por: Wang, Wei, et al.
Publicado: (2021)